SCHEMBL6046657

SCHEMBL6046657

COc1ccc(C(=O)c2ccccc2)c(C(=O)N(C)C(C)C(=O)O)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.56
LMNA P02545 4/20 0.56
HTT P42858 4/20 0.56
CYP1A2 P05177 3/20 0.56
CYP2C19 P33261 2/20 0.56
HPGD P15428 2/20 0.56
MAPK1 P28482 2/20 0.56
PGR P06401 1/20 0.56
CYP2D6 P10635 1/20 0.56
SLC6A2 P23975 1/20 0.56
PDE4A P27815 1/20 0.56
HRH1 P35367 1/20 0.56
SLC6A3 Q01959 1/20 0.56
PDE4D Q08499 1/20 0.56
POLB P06746 2/20 0.52
SMN1; SMN2 Q16637 5/20 0.46
KMT2A Q03164 4/20 0.46
RAB9A P51151 3/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
MAPT P10636 6/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13248615 0.80 ALDH1A1 (0.58) ALDH1A1LMNAHTTCYP1A2CYP2C19
SCHEMBL3480817 0.79 LMNA (0.57) ALDH1A1LMNAHTTCYP1A2CYP2C19
SCHEMBL3480945 0.78 ALDH1A1 (0.71) ALDH1A1LMNAHTTCYP1A2CYP2C19
SCHEMBL3866410 0.77 LMNA (0.54) ALDH1A1LMNAHTTCYP1A2CYP2C19
SCHEMBL699230 0.75 ALDH1A1 (0.71) ALDH1A1LMNAHTTCYP1A2CYP2C19
SCHEMBL29587928 0.74 LMNA (0.66) ALDH1A1LMNAHTTCYP1A2CYP2C19
SCHEMBL8192846 0.73 ALDH1A1 (0.64) ALDH1A1LMNAHTTCYP1A2CYP2C19
SCHEMBL11238917 0.73 PGR (0.46) ALDH1A1LMNAHTTHPGDPGR
SCHEMBL28307954 0.73 PGR (0.46) ALDH1A1LMNAHTTHPGDPGR
SCHEMBL11238921 0.73 PGR (0.46) ALDH1A1LMNAHTTHPGDPGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060270704-A1 Isoquinolinone potassium channel inhibitors MERCK SHARP & DOHME CORP. 2006-11-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060270704-A1 Isoquinolinone potassium channel inhibitors KCNJ2, KCNQ1, KCNQ2 ALDH1A1 1413/4885LMNA 622/4885HTT 3052/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.